<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01916681</url>
  </required_header>
  <id_info>
    <org_study_id>817897</org_study_id>
    <nct_id>NCT01916681</nct_id>
  </id_info>
  <brief_title>Foley OR MisO for the Management of Induction</brief_title>
  <acronym>FORMOMI</acronym>
  <official_title>Foley OR MisO for the Management of Induction (FOR MOMI) Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The percentage of women undergoing an induction of labor (IOL) is estimated to be 20% and
      continues to rise. Simultaneously, the cesarean delivery (CD) rate has continued to increase
      (2). Induction is a known risk factor for CD. Despite numerous studies evaluating time
      periods to define a failed IOL, there are no guidelines or accepted definitions of when to
      call an IOL failed given the incremental gain in vaginal delivery when IOL is prolonged.
      While decreasing the CD rate is an important primary focus in obstetrics, attention must also
      be paid to the overall length of labor given that prolonged labor is associated with adverse
      maternal and neonatal outcomes. Furthermore, a prolonged labor is associated with an increase
      in direct hospital costs and healthcare utilization. The use of cervical ripening agents,
      such as vaginal prostaglandin and mechanical dilators, has been demonstrated to reduce labor
      time and CD rate. In addition to specific individual agents, certain dosing and regimens for
      IOL and active labor have been compared to evaluate whether a particular dose or regimen can
      decrease the length of labor and decrease the CD rate. Most of these regimens; however, focus
      on individual induction agents and few have compared the efficacy of using more than one
      agent simultaneously. Given the associated risks of prolonged labor and limited data
      evaluating the use of combined cervical ripening agents, our objective is to evaluate the
      difference in time to delivery among women who undergo an IOL with four different methods.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prolonged labor increases the risk of maternal and neonatal morbidity as well as increases
      healthcare costs. There is limited data evaluating the use of two simultaneous induction
      agents to decrease the time to delivery.

        1. Maternal and neonatal morbidity with prolonged labor The adverse maternal and neonatal
           morbidity association with prolonged labor has been demonstrated in numerous studies. An
           increase in maternal risk of post partum hemorrhage and endometritis has been associated
           with prolonged labor. Cheng et al demonstrated that the risk of post partum hemorrhage
           and endometritis significantly increased with increasing length of labor. Maghoma et al
           evaluated the latent phase of labor and found a similar increased risk in endometritis
           but also noted a significant risk in maternal sepsis with a prolonged latent phase of
           labor.

           Neonatal outcomes are similarly improved with a shorter duration of labor. In addition
           to the risk of chorioamnionitis and decreased 5 minute Apgar score, there is also a
           significantly increased risk of neonatal intensive care unit admission as well as
           neonatal sepsis with prolonged labor.

        2. Increased healthcare utilization with prolonged labor Both direct and indirect medical
           costs have been evaluated in the obstetrics literature. A prolonged labor has been
           associated with an increase in direct and indirect medical costs as well as an increase
           in healthcare utilization. Mackenzie et al evaluated the cost of different induction
           regimens and found a decreased cost for women that remained on the antenatal unit for a
           shorter period of time.

        3. Use of simultaneous induction agents Pettker et al evaluated the use of a transcervical
           foley with and without oxytocin and found no difference in mode of delivery or delivery
           within 24 hours. They found that labor was 2.5 hours shorter with the addition of
           oxytocin although the study was not powered to see a statistical difference. Other
           studies have looked at the concurrent use of prostaglandin with cervical foley.
           Barrilleaux et al evaluated the use of oral misoprostol with cervical foley compared to
           cervical foley alone and found no difference in time to delivery; however, the use of
           oral misprostol has well known side effects, including a high rate of tachysystole which
           was found in this study. Hill et al reported a decreased time to second stage and time
           to delivery with the use of cervical foley and oral misoprostol compared to vaginal
           misoprostol alone; however this was a small study that used with a higher, more
           favorable starting Bishop score in the combined foley+misoprostol group, biasing them
           away from the null. Standardized time cut offs during IOL were not used in this study.
           Recently, Carbone et al performed a randomized trial comparing foley bulb and misprostol
           to misoprostol alone and found a decreased time to delivery among those in the combined
           group. This study was a small trial with 60 patients in each arm and did not compare the
           combined agents to cervical foley alone.

        4. Standardization of IOL The optimal length for an IOL is not well established and data on
           definitions of a failed IOL and prolonged latent phase are lacking. Multiple studies
           have shown that within 6 hours of oxytocin administration, 60-70% of patients are in
           active labor. Although data suggest that the longer latent labor is allowed to proceed,
           the more women that will deliver vaginally, there is also evidence of an increased risk
           of morbidity, without a large incremental gain. Certain dosing and regimens of
           individual agents have been evaluated to try and decrease labor; however, studies have
           not evaluated the use of time cut offs during an IOL to help reduce variation in
           practice and standardize the IOL process.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Delivery</measure>
    <time_frame>Hours between start of induction to delivery</time_frame>
    <description>Amount of hours that pass between the start of the induction to delivery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Length of Stay</measure>
    <time_frame>Days between admit to hospital and discharge</time_frame>
    <description>Total maternal length of stay as defined as days from the day the induction began to the day of discharge</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severe RDS</measure>
    <time_frame>enrollment through neonatal discharge</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mode of Delivery</measure>
    <time_frame>Start of induction to delivery</time_frame>
    <description>Cesarean Delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Active Labor</measure>
    <time_frame>Start of induction to active labor</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Regional Anesthesia</measure>
    <time_frame>During delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chorioamnionitis</measure>
    <time_frame>Enrollment through deischarge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal Morbidity</measure>
    <time_frame>Enrollment through discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">491</enrollment>
  <condition>Delivery; Prolonged</condition>
  <arm_group>
    <arm_group_label>Cervical foley &amp; Misoprostol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to this arm will receive a cervical foley and misoprostol to induce their labor.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Misoprostol only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to this arm will receive misoprostol only to induce their labor.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cervical foley alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to this arm will receive a cervical foley to induce their labor.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cervical foley &amp; Pitocin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients randomized to this arm will receive a cervical foley and pitocin to induce their labor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cervical Foley &amp; Misoprostol</intervention_name>
    <description>A cervical foley combined with misoprostol will be used to induce the patient.</description>
    <arm_group_label>Cervical foley &amp; Misoprostol</arm_group_label>
    <other_name>Misoprostol is also known as Cytotec</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol Alone</intervention_name>
    <description>Misoprostol will be used alone to induce the patient</description>
    <arm_group_label>Misoprostol only</arm_group_label>
    <other_name>Misoprostol is also known as Cytotec</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cervical Foley Alone</intervention_name>
    <description>A cervical foley alone will be used to induce the patient</description>
    <arm_group_label>Cervical foley alone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cervical Foley &amp; Pitocin</intervention_name>
    <description>A cervical foley combined with pitocin will be used to induce the patient</description>
    <arm_group_label>Cervical foley &amp; Pitocin</arm_group_label>
    <other_name>Pitocin is also known as Oxytocin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All women 18 years of age or greater

          -  singleton gestation

          -  vertex presentation

          -  37 weeks gestational age or greater

          -  undergoing an IOL

          -  bishop score less than or equal to 6

          -  cervical dilation less than or equal to 2cm

        Exclusion Criteria:

          -  All women less than 18 years of age

          -  Contraindication for vaginal delivery

          -  Prior cesarean delivery

          -  Multiple gestation

          -  Intrauterine fetal demise

          -  Fetal anomaly

          -  HIV

          -  Unable to consent/ non-English speaking

          -  Non-reassuring fetal heart rate

          -  Patients with hemolysis elevated liver enzymes and low platelets

          -  Eclampsia

          -  Intrauterine growth restriction (IUGR) 5th percentile with abnormal dopplers

          -  IUGR less than 10th percentile with reversed end diastolic flow

          -  Recurrent late decelerations w

          -  Continuous contractions more than 3 times in 10 minutes at onset of IOL (given that
             this is a contraindication to misoprostol use at our institution)

          -  Bishop score is greater than 6

          -  Cervical dilation greater than or equal to 2cm

          -  Confirmed ruptured membranes
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa D Levine, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 30, 2013</study_first_submitted>
  <study_first_submitted_qc>August 1, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2013</study_first_posted>
  <results_first_submitted>October 5, 2016</results_first_submitted>
  <results_first_submitted_qc>October 26, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 21, 2016</results_first_posted>
  <last_update_submitted>April 10, 2017</last_update_submitted>
  <last_update_submitted_qc>April 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Induction</keyword>
  <keyword>Labor</keyword>
  <keyword>Cervical foley</keyword>
  <keyword>Misoprostol</keyword>
  <keyword>Pitocin</keyword>
  <keyword>Oxytocin</keyword>
  <keyword>Cytotec</keyword>
  <keyword>Delivery</keyword>
  <keyword>IOL</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Cervical Foley &amp; Misoprostol</title>
          <description>Patients randomized to this arm will receive a cervical foley and misoprostol to induce their labor.
Cervical Foley &amp; Misoprostol: A cervical foley combined with misoprostol will be used to induce the patient.</description>
        </group>
        <group group_id="P2">
          <title>Misoprostol Only</title>
          <description>Patients randomized to this arm will receive misoprostol to induce their labor.
Misoprostol Alone: Misoprostol will be used alone to induce the patient</description>
        </group>
        <group group_id="P3">
          <title>Cervical Foley Alone</title>
          <description>Patients randomized to this arm will receive a cervical foley to induce their labor.
Cervical Foley Alone: A cervical foley alone will be used to induce the patient</description>
        </group>
        <group group_id="P4">
          <title>Cervical Foley &amp; Pitocin</title>
          <description>Patients randomized to this arm will receive a cervical foley and pitocin to induce their labor.
Cervical Foley &amp; Oxytocin: A cervical foley combined with oxytocin will be used to induce the patient</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="123"/>
                <participants group_id="P2" count="120"/>
                <participants group_id="P3" count="123"/>
                <participants group_id="P4" count="125"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="123"/>
                <participants group_id="P2" count="120"/>
                <participants group_id="P3" count="123"/>
                <participants group_id="P4" count="125"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cervical Foley &amp; Misoprostol</title>
          <description>Patients randomized to this arm will receive a cervical foley and misoprostol to induce their labor.
Cervical Foley &amp; Misoprostol: A cervical foley combined with misoprostol will be used to induce the patient.</description>
        </group>
        <group group_id="B2">
          <title>Misoprostol Only</title>
          <description>Patients randomized to this arm will receive misoprostol to induce their labor.
Misoprostol Alone: Misoprostol will be used alone to induce the patient</description>
        </group>
        <group group_id="B3">
          <title>Cervical Foley Alone</title>
          <description>Patients randomized to this arm will receive a cervical foley to induce their labor.
Cervical Foley Alone: A cervical foley alone will be used to induce the patient</description>
        </group>
        <group group_id="B4">
          <title>Cervical Foley &amp; Pitocin</title>
          <description>Patients randomized to this arm will receive a cervical foley and pitocin to induce their labor.
Cervical Foley &amp; Pitocin: A cervical foley combined with pitocin will be used to induce the patient</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="123"/>
            <count group_id="B2" value="120"/>
            <count group_id="B3" value="123"/>
            <count group_id="B4" value="125"/>
            <count group_id="B5" value="491"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="123"/>
                    <measurement group_id="B2" value="120"/>
                    <measurement group_id="B3" value="123"/>
                    <measurement group_id="B4" value="125"/>
                    <measurement group_id="B5" value="491"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>Years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28" lower_limit="22.4" upper_limit="33.1"/>
                    <measurement group_id="B2" value="26.7" lower_limit="21.8" upper_limit="31.0"/>
                    <measurement group_id="B3" value="27.3" lower_limit="22.3" upper_limit="32.9"/>
                    <measurement group_id="B4" value="26.5" lower_limit="22.4" upper_limit="31.7"/>
                    <measurement group_id="B5" value="27" lower_limit="22" upper_limit="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="123"/>
                    <measurement group_id="B2" value="120"/>
                    <measurement group_id="B3" value="123"/>
                    <measurement group_id="B4" value="125"/>
                    <measurement group_id="B5" value="491"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="123"/>
                    <measurement group_id="B2" value="120"/>
                    <measurement group_id="B3" value="123"/>
                    <measurement group_id="B4" value="125"/>
                    <measurement group_id="B5" value="491"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to Delivery</title>
        <description>Amount of hours that pass between the start of the induction to delivery.</description>
        <time_frame>Hours between start of induction to delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cervical Foley &amp; Misoprostol</title>
            <description>Patients randomized to this arm will receive a cervical foley and misoprostol to induce their labor.
Cervical Foley &amp; Misoprostol: A cervical foley combined with misoprostol will be used to induce the patient.</description>
          </group>
          <group group_id="O2">
            <title>Misoprostol Only</title>
            <description>Patients randomized to this arm will receive misoprostol to induce their labor.
Misoprostol Alone: Misoprostol will be used alone to induce the patient</description>
          </group>
          <group group_id="O3">
            <title>Cervical Foley Alone</title>
            <description>Patients randomized to this arm will receive a cervical foley to induce their labor.
Cervical Foley Alone: A cervical foley alone will be used to induce the patient</description>
          </group>
          <group group_id="O4">
            <title>Cervical Foley &amp; Pitocin</title>
            <description>Patients randomized to this arm will receive a cervical foley and pitocin to induce their labor.
Cervical Foley &amp; Pitocin: A cervical foley combined with pitocin will be used to induce the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Delivery</title>
          <description>Amount of hours that pass between the start of the induction to delivery.</description>
          <units>Hours</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="123"/>
                <count group_id="O2" value="120"/>
                <count group_id="O3" value="123"/>
                <count group_id="O4" value="125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.1" lower_limit="9.1" upper_limit="18.3"/>
                    <measurement group_id="O2" value="17.6" lower_limit="11.9" upper_limit="26.7"/>
                    <measurement group_id="O3" value="17.7" lower_limit="12.6" upper_limit="24.9"/>
                    <measurement group_id="O4" value="14.5" lower_limit="9.3" upper_limit="20.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Length of Stay</title>
        <description>Total maternal length of stay as defined as days from the day the induction began to the day of discharge</description>
        <time_frame>Days between admit to hospital and discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cervical Foley &amp; Misoprostol</title>
            <description>Patients randomized to this arm will receive a cervical foley and misoprostol to induce their labor.
Cervical Foley &amp; Misoprostol: A cervical foley combined with misoprostol will be used to induce the patient.</description>
          </group>
          <group group_id="O2">
            <title>Misoprostol Only</title>
            <description>Patients randomized to this arm will receive misoprostol to induce their labor.
Misoprostol Alone: Misoprostol will be used alone to induce the patient</description>
          </group>
          <group group_id="O3">
            <title>Cervical Foley Alone</title>
            <description>Patients randomized to this arm will receive a cervical foley to induce their labor.
Cervical Foley Alone: A cervical foley alone will be used to induce the patient</description>
          </group>
          <group group_id="O4">
            <title>Cervical Foley &amp; Pitocin</title>
            <description>Patients randomized to this arm will receive a cervical foley and pitocin to induce their labor.
Cervical Foley &amp; Oxytocin: A cervical foley combined with oxytocin will be used to induce the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Stay</title>
          <description>Total maternal length of stay as defined as days from the day the induction began to the day of discharge</description>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="123"/>
                <count group_id="O2" value="120"/>
                <count group_id="O3" value="123"/>
                <count group_id="O4" value="125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="3" upper_limit="4"/>
                    <measurement group_id="O2" value="3" lower_limit="3" upper_limit="4"/>
                    <measurement group_id="O3" value="3" lower_limit="3" upper_limit="4"/>
                    <measurement group_id="O4" value="3" lower_limit="3" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Severe RDS</title>
        <time_frame>enrollment through neonatal discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cervical Foley &amp; Misoprostol</title>
            <description>Patients randomized to this arm will receive a cervical foley and misoprostol to induce their labor.
Cervical Foley &amp; Misoprostol: A cervical foley combined with misoprostol will be used to induce the patient.</description>
          </group>
          <group group_id="O2">
            <title>Misoprostol Only</title>
            <description>Patients randomized to this arm will receive misoprostol to induce their labor.
Misoprostol Alone: Misoprostol will be used alone to induce the patient</description>
          </group>
          <group group_id="O3">
            <title>Cervical Foley Alone</title>
            <description>Patients randomized to this arm will receive a cervical foley to induce their labor.
Cervical Foley Alone: A cervical foley alone will be used to induce the patient</description>
          </group>
          <group group_id="O4">
            <title>Cervical Foley &amp; Pitocin</title>
            <description>Patients randomized to this arm will receive a cervical foley and pitocin to induce their labor.
Cervical Foley &amp; Oxytocin: A cervical foley combined with oxytocin will be used to induce the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Severe RDS</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="123"/>
                <count group_id="O2" value="120"/>
                <count group_id="O3" value="123"/>
                <count group_id="O4" value="125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                    <measurement group_id="O4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mode of Delivery</title>
        <description>Cesarean Delivery</description>
        <time_frame>Start of induction to delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cervical Foley &amp; Misoprostol</title>
            <description>Patients randomized to this arm will receive a cervical foley and misoprostol to induce their labor.
Cervical Foley &amp; Misoprostol: A cervical foley combined with misoprostol will be used to induce the patient.</description>
          </group>
          <group group_id="O2">
            <title>Misoprostol Only</title>
            <description>Patients randomized to this arm will receive misoprostol to induce their labor.
Misoprostol Alone: Misoprostol will be used alone to induce the patient</description>
          </group>
          <group group_id="O3">
            <title>Cervical Foley Alone</title>
            <description>Patients randomized to this arm will receive a cervical foley to induce their labor.
Cervical Foley Alone: A cervical foley alone will be used to induce the patient</description>
          </group>
          <group group_id="O4">
            <title>Cervical Foley &amp; Pitocin</title>
            <description>Patients randomized to this arm will receive a cervical foley and pitocin to induce their labor.
Cervical Foley &amp; Oxytocin: A cervical foley combined with oxytocin will be used to induce the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Mode of Delivery</title>
          <description>Cesarean Delivery</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="123"/>
                <count group_id="O2" value="120"/>
                <count group_id="O3" value="123"/>
                <count group_id="O4" value="125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="29"/>
                    <measurement group_id="O3" value="35"/>
                    <measurement group_id="O4" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Active Labor</title>
        <time_frame>Start of induction to active labor</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cervical Foley &amp; Misoprostol</title>
            <description>Patients randomized to this arm will receive a cervical foley and misoprostol to induce their labor.
Cervical Foley &amp; Misoprostol: A cervical foley combined with misoprostol will be used to induce the patient.</description>
          </group>
          <group group_id="O2">
            <title>Misoprostol Only</title>
            <description>Patients randomized to this arm will receive misoprostol to induce their labor.
Misoprostol Alone: Misoprostol will be used alone to induce the patient</description>
          </group>
          <group group_id="O3">
            <title>Cervical Foley Alone</title>
            <description>Patients randomized to this arm will receive a cervical foley to induce their labor.
Cervical Foley Alone: A cervical foley alone will be used to induce the patient</description>
          </group>
          <group group_id="O4">
            <title>Cervical Foley &amp; Pitocin</title>
            <description>Patients randomized to this arm will receive a cervical foley and pitocin to induce their labor.
Cervical Foley &amp; Oxytocin: A cervical foley combined with oxytocin will be used to induce the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Active Labor</title>
          <units>Hours</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="123"/>
                <count group_id="O2" value="120"/>
                <count group_id="O3" value="123"/>
                <count group_id="O4" value="125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" lower_limit="4.4" upper_limit="10.7"/>
                    <measurement group_id="O2" value="13.3" lower_limit="9.1" upper_limit="22.4"/>
                    <measurement group_id="O3" value="11.0" lower_limit="7.9" upper_limit="14.9"/>
                    <measurement group_id="O4" value="8.1" lower_limit="5.3" upper_limit="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Regional Anesthesia</title>
        <time_frame>During delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cervical Foley &amp; Misoprostol</title>
            <description>Patients randomized to this arm will receive a cervical foley and misoprostol to induce their labor.
Cervical Foley &amp; Misoprostol: A cervical foley combined with misoprostol will be used to induce the patient.</description>
          </group>
          <group group_id="O2">
            <title>Misoprostol Only</title>
            <description>Patients randomized to this arm will receive misoprostol to induce their labor.
Misoprostol Alone: Misoprostol will be used alone to induce the patient</description>
          </group>
          <group group_id="O3">
            <title>Cervical Foley Alone</title>
            <description>Patients randomized to this arm will receive a cervical foley to induce their labor.
Cervical Foley Alone: A cervical foley alone will be used to induce the patient</description>
          </group>
          <group group_id="O4">
            <title>Cervical Foley &amp; Pitocin</title>
            <description>Patients randomized to this arm will receive a cervical foley and pitocin to induce their labor.
Cervical Foley &amp; Oxytocin: A cervical foley combined with oxytocin will be used to induce the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Regional Anesthesia</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="123"/>
                <count group_id="O2" value="120"/>
                <count group_id="O3" value="123"/>
                <count group_id="O4" value="125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="114"/>
                    <measurement group_id="O2" value="111"/>
                    <measurement group_id="O3" value="114"/>
                    <measurement group_id="O4" value="121"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Chorioamnionitis</title>
        <time_frame>Enrollment through deischarge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cervical Foley &amp; Misoprostol</title>
            <description>Patients randomized to this arm will receive a cervical foley and misoprostol to induce their labor.
Cervical Foley &amp; Misoprostol: A cervical foley combined with misoprostol will be used to induce the patient.</description>
          </group>
          <group group_id="O2">
            <title>Misoprostol Only</title>
            <description>Patients randomized to this arm will receive misoprostol to induce their labor.
Misoprostol Alone: Misoprostol will be used alone to induce the patient</description>
          </group>
          <group group_id="O3">
            <title>Cervical Foley Alone</title>
            <description>Patients randomized to this arm will receive a cervical foley to induce their labor.
Cervical Foley Alone: A cervical foley alone will be used to induce the patient</description>
          </group>
          <group group_id="O4">
            <title>Cervical Foley &amp; Pitocin</title>
            <description>Patients randomized to this arm will receive a cervical foley and pitocin to induce their labor.
Cervical Foley &amp; Oxytocin: A cervical foley combined with oxytocin will be used to induce the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Chorioamnionitis</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="123"/>
                <count group_id="O2" value="120"/>
                <count group_id="O3" value="123"/>
                <count group_id="O4" value="125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="9"/>
                    <measurement group_id="O3" value="17"/>
                    <measurement group_id="O4" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maternal Morbidity</title>
        <time_frame>Enrollment through discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cervical Foley &amp; Misoprostol</title>
            <description>Patients randomized to this arm will receive a cervical foley and misoprostol to induce their labor.
Cervical Foley &amp; Misoprostol: A cervical foley combined with misoprostol will be used to induce the patient.</description>
          </group>
          <group group_id="O2">
            <title>Misoprostol Only</title>
            <description>Patients randomized to this arm will receive misoprostol to induce their labor.
Misoprostol Alone: Misoprostol will be used alone to induce the patient</description>
          </group>
          <group group_id="O3">
            <title>Cervical Foley Alone</title>
            <description>Patients randomized to this arm will receive a cervical foley to induce their labor.
Cervical Foley Alone: A cervical foley alone will be used to induce the patient</description>
          </group>
          <group group_id="O4">
            <title>Cervical Foley &amp; Pitocin</title>
            <description>Patients randomized to this arm will receive a cervical foley and pitocin to induce their labor.
Cervical Foley &amp; Oxytocin: A cervical foley combined with oxytocin will be used to induce the patient</description>
          </group>
        </group_list>
        <measure>
          <title>Maternal Morbidity</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="123"/>
                <count group_id="O2" value="120"/>
                <count group_id="O3" value="123"/>
                <count group_id="O4" value="125"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="13"/>
                    <measurement group_id="O4" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 6 weeks postpartum.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Cervical Foley &amp; Misoprostol</title>
          <description>Patients randomized to this arm will receive a cervical foley and misoprostol to induce their labor.
Cervical Foley &amp; Misoprostol: A cervical foley combined with misoprostol will be used to induce the patient.</description>
        </group>
        <group group_id="E2">
          <title>Misoprostol Only</title>
          <description>Patients randomized to this arm will receive misoprostol to induce their labor.
Misoprostol Alone: Misoprostol will be used alone to induce the patient</description>
        </group>
        <group group_id="E3">
          <title>Cervical Foley Alone</title>
          <description>Patients randomized to this arm will receive a cervical foley to induce their labor.
Cervical Foley Alone: A cervical foley alone will be used to induce the patient</description>
        </group>
        <group group_id="E4">
          <title>Cervical Foley &amp; Pitocin</title>
          <description>Patients randomized to this arm will receive a cervical foley and pitocin to induce their labor.
Cervical Foley &amp; Oxytocin: A cervical foley combined with oxytocin will be used to induce the patient</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>Chorioamnionitis</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="30" subjects_at_risk="123"/>
                <counts group_id="E2" subjects_affected="33" subjects_at_risk="120"/>
                <counts group_id="E3" subjects_affected="46" subjects_at_risk="123"/>
                <counts group_id="E4" subjects_affected="46" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Chorioamnionitis</sub_title>
                <description>Defined by use of antibiotics during labor not for GBS+ or other known infection.</description>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="123"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="120"/>
                <counts group_id="E3" events="17" subjects_affected="17" subjects_at_risk="123"/>
                <counts group_id="E4" events="20" subjects_affected="20" subjects_at_risk="125"/>
              </event>
              <event>
                <sub_title vocab="Endometritis">Endometritis</sub_title>
                <description>Diagnosed and treated based on maternal fever (&gt;100.4) in the setting of either (1) fundal tenderness or (2) maternal tachycardia</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="125"/>
              </event>
              <event>
                <sub_title vocab="Wound Infection">Wound Infection</sub_title>
                <description>Diagnosed on chart review by provider documenting a diagnosis of cellulitis, need for antibiotics to treat wound, wound separation, purulent discharge from wound, abscess, or need for debridement.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="123"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="123"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="125"/>
              </event>
              <event>
                <sub_title vocab="Venous Thromboemboli">Venous Thromboembolism</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="125"/>
              </event>
              <event>
                <sub_title>Maternal blood transfusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="123"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="120"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="123"/>
                <counts group_id="E4" events="4" subjects_affected="4" subjects_at_risk="125"/>
              </event>
              <event>
                <sub_title>Postpartum readmission</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="123"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="120"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="123"/>
                <counts group_id="E4" events="7" subjects_affected="7" subjects_at_risk="125"/>
              </event>
              <event>
                <sub_title>NICU admission</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="123"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="120"/>
                <counts group_id="E3" events="17" subjects_affected="17" subjects_at_risk="123"/>
                <counts group_id="E4" events="11" subjects_affected="11" subjects_at_risk="125"/>
              </event>
              <event>
                <sub_title>Neonatal blood transfusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="125"/>
              </event>
              <event>
                <sub_title>Hypoxic-ischemic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="125"/>
              </event>
              <event>
                <sub_title>Intraventricular hemorrhage Grade 3 or 4</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="125"/>
              </event>
              <event>
                <sub_title>Severe respiratory distress</sub_title>
                <description>Intubation and mechanical ventilation for a minimum of 12 hours.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="120"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="123"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="125"/>
              </event>
              <event>
                <sub_title>Necrotizing enterocolitis or rule out NEC</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="125"/>
              </event>
              <event>
                <sub_title>Culture proven neonatal sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="120"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="123"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="125"/>
              </event>
              <event>
                <sub_title>Presumed Sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="123"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="120"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="123"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Lisa Levine</name_or_title>
      <organization>University of Pennsylvania</organization>
      <phone>2156626913</phone>
      <email>lisa.levine@uphs.upenn.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

